Selected research
Industry Research
Exosome Service Industry Research Report 2026
Market perspective
The global Exosome Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Exosome Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Exosome Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Exosome Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Exosome Service include LipExoGen Biotech, Creative Biostructure, Immunostep Biotech, AMSBIO, Frontage Labs, EVerZom, System Biosicences (SBI), Exosome Diagnostics and Creative Bioarray, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Exosome Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Exosome Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Exosome Service Market by Company
LipExoGen Biotech
Creative Biostructure
Immunostep Biotech
AMSBIO
Frontage Labs
EVerZom
System Biosicences (SBI)
Exosome Diagnostics
Creative Bioarray
Exosomics
Creative Proteomics
RoosterBio
Clara Biotech
Luminous BioSciences
Capital Biosciences
Anazao
Alpha Nano Tech
NCELL
Wayen Biotechnologies (Shanghai)
Shanghai Yanjiang Biotechnology
Exosome Service Segment by Type
Exosome Isolation
Exosome Identification
Exosome Analysis
Other
Exosome Service Segment by Application
Medicine
Biological
Other
Exosome Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Exosome Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Exosome Isolation
- Exosome Identification
- Exosome Analysis
- Other
Applications
- Medicine
- Biological
- Other
Companies covered
- LipExoGen Biotech
- Creative Biostructure
- Immunostep Biotech
- AMSBIO
- Frontage Labs
- EVerZom
- System Biosicences (SBI)
- Exosome Diagnostics
- Creative Bioarray
- Exosomics
- Creative Proteomics
- RoosterBio
- Clara Biotech
- Luminous BioSciences
- Capital Biosciences
- Anazao
- Alpha Nano Tech
- NCELL
- Wayen Biotechnologies (Shanghai)
- Shanghai Yanjiang Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Exosome Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Exosome Isolation
- 2.2.3 Exosome Identification
- 2.2.4 Exosome Analysis
- 2.2.5 Other
- 2.3 Exosome Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medicine
- 2.3.3 Biological
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Exosome Service Breakdown Data by Type
- 3.1 Global Exosome Service Historic Market Size by Type (2021-2026)
- 3.2 Global Exosome Service Forecasted Market Size by Type (2027-2032)
4 Exosome Service Breakdown Data by Application
- 4.1 Global Exosome Service Historic Market Size by Application (2021-2026)
- 4.2 Global Exosome Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Exosome Service Market Perspective (2021-2032)
- 5.2 Global Exosome Service Growth Trends by Region
- 5.2.1 Global Exosome Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Exosome Service Historic Market Size by Region (2021-2026)
- 5.2.3 Exosome Service Forecasted Market Size by Region (2027-2032)
- 5.3 Exosome Service Market Dynamics
- 5.3.1 Exosome Service Industry Trends
- 5.3.2 Exosome Service Market Drivers
- 5.3.3 Exosome Service Market Challenges
- 5.3.4 Exosome Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Exosome Service Players by Revenue
- 6.1.1 Global Top Exosome Service Players by Revenue (2021-2026)
- 6.1.2 Global Exosome Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Exosome Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Exosome Service Head Office and Area Served
- 6.4 Global Exosome Service Players, Product Type & Application
- 6.5 Global Exosome Service Manufacturers Established Date
- 6.6 Global Exosome Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Exosome Service Market Size (2021-2032)
- 7.2 North America Exosome Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Exosome Service Market Size by Country (2021-2026)
- 7.4 North America Exosome Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Exosome Service Market Size (2021-2032)
- 8.2 Europe Exosome Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Exosome Service Market Size by Country (2021-2026)
- 8.4 Europe Exosome Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Exosome Service Market Size (2021-2032)
- 9.2 Asia-Pacific Exosome Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Exosome Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Exosome Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Exosome Service Market Size (2021-2032)
- 10.2 South America Exosome Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Exosome Service Market Size by Country (2021-2026)
- 10.4 South America Exosome Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Exosome Service Market Size (2021-2032)
- 11.2 Middle East & Africa Exosome Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Exosome Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Exosome Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 LipExoGen Biotech
- 12.1.1 LipExoGen Biotech Company Information
- 12.1.2 LipExoGen Biotech Business Overview
- 12.1.3 LipExoGen Biotech Revenue in Exosome Service Business (2021-2026)
- 12.1.4 LipExoGen Biotech Exosome Service Product Portfolio
- 12.1.5 LipExoGen Biotech Recent Developments
- 12.2 Creative Biostructure
- 12.2.1 Creative Biostructure Company Information
- 12.2.2 Creative Biostructure Business Overview
- 12.2.3 Creative Biostructure Revenue in Exosome Service Business (2021-2026)
- 12.2.4 Creative Biostructure Exosome Service Product Portfolio
- 12.2.5 Creative Biostructure Recent Developments
- 12.3 Immunostep Biotech
- 12.3.1 Immunostep Biotech Company Information
- 12.3.2 Immunostep Biotech Business Overview
- 12.3.3 Immunostep Biotech Revenue in Exosome Service Business (2021-2026)
- 12.3.4 Immunostep Biotech Exosome Service Product Portfolio
- 12.3.5 Immunostep Biotech Recent Developments
- 12.4 AMSBIO
- 12.4.1 AMSBIO Company Information
- 12.4.2 AMSBIO Business Overview
- 12.4.3 AMSBIO Revenue in Exosome Service Business (2021-2026)
- 12.4.4 AMSBIO Exosome Service Product Portfolio
- 12.4.5 AMSBIO Recent Developments
- 12.5 Frontage Labs
- 12.5.1 Frontage Labs Company Information
- 12.5.2 Frontage Labs Business Overview
- 12.5.3 Frontage Labs Revenue in Exosome Service Business (2021-2026)
- 12.5.4 Frontage Labs Exosome Service Product Portfolio
- 12.5.5 Frontage Labs Recent Developments
- 12.6 EVerZom
- 12.6.1 EVerZom Company Information
- 12.6.2 EVerZom Business Overview
- 12.6.3 EVerZom Revenue in Exosome Service Business (2021-2026)
- 12.6.4 EVerZom Exosome Service Product Portfolio
- 12.6.5 EVerZom Recent Developments
- 12.7 System Biosicences (SBI)
- 12.7.1 System Biosicences (SBI) Company Information
- 12.7.2 System Biosicences (SBI) Business Overview
- 12.7.3 System Biosicences (SBI) Revenue in Exosome Service Business (2021-2026)
- 12.7.4 System Biosicences (SBI) Exosome Service Product Portfolio
- 12.7.5 System Biosicences (SBI) Recent Developments
- 12.8 Exosome Diagnostics
- 12.8.1 Exosome Diagnostics Company Information
- 12.8.2 Exosome Diagnostics Business Overview
- 12.8.3 Exosome Diagnostics Revenue in Exosome Service Business (2021-2026)
- 12.8.4 Exosome Diagnostics Exosome Service Product Portfolio
- 12.8.5 Exosome Diagnostics Recent Developments
- 12.9 Creative Bioarray
- 12.9.1 Creative Bioarray Company Information
- 12.9.2 Creative Bioarray Business Overview
- 12.9.3 Creative Bioarray Revenue in Exosome Service Business (2021-2026)
- 12.9.4 Creative Bioarray Exosome Service Product Portfolio
- 12.9.5 Creative Bioarray Recent Developments
- 12.10 Exosomics
- 12.10.1 Exosomics Company Information
- 12.10.2 Exosomics Business Overview
- 12.10.3 Exosomics Revenue in Exosome Service Business (2021-2026)
- 12.10.4 Exosomics Exosome Service Product Portfolio
- 12.10.5 Exosomics Recent Developments
- 12.11 Creative Proteomics
- 12.11.1 Creative Proteomics Company Information
- 12.11.2 Creative Proteomics Business Overview
- 12.11.3 Creative Proteomics Revenue in Exosome Service Business (2021-2026)
- 12.11.4 Creative Proteomics Exosome Service Product Portfolio
- 12.11.5 Creative Proteomics Recent Developments
- 12.12 RoosterBio
- 12.12.1 RoosterBio Company Information
- 12.12.2 RoosterBio Business Overview
- 12.12.3 RoosterBio Revenue in Exosome Service Business (2021-2026)
- 12.12.4 RoosterBio Exosome Service Product Portfolio
- 12.12.5 RoosterBio Recent Developments
- 12.13 Clara Biotech
- 12.13.1 Clara Biotech Company Information
- 12.13.2 Clara Biotech Business Overview
- 12.13.3 Clara Biotech Revenue in Exosome Service Business (2021-2026)
- 12.13.4 Clara Biotech Exosome Service Product Portfolio
- 12.13.5 Clara Biotech Recent Developments
- 12.14 Luminous BioSciences
- 12.14.1 Luminous BioSciences Company Information
- 12.14.2 Luminous BioSciences Business Overview
- 12.14.3 Luminous BioSciences Revenue in Exosome Service Business (2021-2026)
- 12.14.4 Luminous BioSciences Exosome Service Product Portfolio
- 12.14.5 Luminous BioSciences Recent Developments
- 12.15 Capital Biosciences
- 12.15.1 Capital Biosciences Company Information
- 12.15.2 Capital Biosciences Business Overview
- 12.15.3 Capital Biosciences Revenue in Exosome Service Business (2021-2026)
- 12.15.4 Capital Biosciences Exosome Service Product Portfolio
- 12.15.5 Capital Biosciences Recent Developments
- 12.16 Anazao
- 12.16.1 Anazao Company Information
- 12.16.2 Anazao Business Overview
- 12.16.3 Anazao Revenue in Exosome Service Business (2021-2026)
- 12.16.4 Anazao Exosome Service Product Portfolio
- 12.16.5 Anazao Recent Developments
- 12.17 Alpha Nano Tech
- 12.17.1 Alpha Nano Tech Company Information
- 12.17.2 Alpha Nano Tech Business Overview
- 12.17.3 Alpha Nano Tech Revenue in Exosome Service Business (2021-2026)
- 12.17.4 Alpha Nano Tech Exosome Service Product Portfolio
- 12.17.5 Alpha Nano Tech Recent Developments
- 12.18 NCELL
- 12.18.1 NCELL Company Information
- 12.18.2 NCELL Business Overview
- 12.18.3 NCELL Revenue in Exosome Service Business (2021-2026)
- 12.18.4 NCELL Exosome Service Product Portfolio
- 12.18.5 NCELL Recent Developments
- 12.19 Wayen Biotechnologies (Shanghai)
- 12.19.1 Wayen Biotechnologies (Shanghai) Company Information
- 12.19.2 Wayen Biotechnologies (Shanghai) Business Overview
- 12.19.3 Wayen Biotechnologies (Shanghai) Revenue in Exosome Service Business (2021-2026)
- 12.19.4 Wayen Biotechnologies (Shanghai) Exosome Service Product Portfolio
- 12.19.5 Wayen Biotechnologies (Shanghai) Recent Developments
- 12.20 Shanghai Yanjiang Biotechnology
- 12.20.1 Shanghai Yanjiang Biotechnology Company Information
- 12.20.2 Shanghai Yanjiang Biotechnology Business Overview
- 12.20.3 Shanghai Yanjiang Biotechnology Revenue in Exosome Service Business (2021-2026)
- 12.20.4 Shanghai Yanjiang Biotechnology Exosome Service Product Portfolio
- 12.20.5 Shanghai Yanjiang Biotechnology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst